The beauty industry faces a sluggish start to 2025, but companies remain hopeful for a gradual recovery later in the year.

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...

The price of gold has been bursting through records in the first month of Trump’s second term and among the explanations is that the US President coul ...

Complacency has ruled the markets since December and since Donald Trump’s inauguration. But beneath the surface a variety of ...

From the beginning, the Senate Budget Committee’s bipartisan goal was to ‘leave no stone unturned’ in pursuit of justice for ...

There are plenty of compelling reasons for branching further into the many areas related to wealth management. But experts warn there are challenges, as well.

UBS has pulled a three-person advisory team from the RIA aggregator Cresset Capital. The move goes against the prevailing ...

A busy Washington news cycle has left markets relatively unscathed--but not for long, UBS warns. The bank says stock market ...

Fintel reports that on February 21, 2025, UBS downgraded their outlook for TFI International (NYSE:TFII) from Buy to Neutral. Analyst Price Forecast Suggests 40.15% Upside As of January 29, 2025, the ...

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI ...

SentinelOne's market cap is only $7.8 billion, trading at 7 times sales, much lower than peers like CrowdStrike, Palo Alto Networks, and Zscaler. Learn more on S stock here.